Original data study · federal multidistrict litigation
Which mass torts grew fastest? 12 months of federal MDL data
We compared 13 monthly reports from the Judicial Panel on Multidistrict Litigation to see which federal mass-tort dockets gained the most pending actions in a year.
By the People's Justice research team · Published
Data: JPML reports dated , to
Key findings
Pending actions in the Depo-Provera MDL (MDL 3140) rose from 1,225 to 6,413 between the JPML reports dated November 3, 2025, and November 2, 2026, a 424% increase and the largest increase of any federal MDL, both in number and in percentage terms.
Source: JPML report, November 3, 2025 (PDF); JPML report, November 2, 2026 (PDF)
Three other MDLs with at least 1,000 pending actions grew by more than half over the same 12 months: Bard implanted port catheter (MDL 3081, up 104% to 4,345), social media adolescent addiction (MDL 3047, up 98% to 4,309) and Uber passenger sexual assault (MDL 3084, up 63% to 4,548), according to the same JPML reports.
Source: JPML report, November 3, 2025 (PDF); JPML report, November 2, 2026 (PDF)
Across all federal MDLs, pending actions rose 3.5%, from 197,981 to 204,987, and the number of MDL dockets went from 157 to 164 (27 MDLs were added to the report and 20 were no longer listed) between the JPML reports dated November 3, 2025, and November 2, 2026.
Source: JPML report, November 3, 2025 (PDF); JPML report, November 2, 2026 (PDF)
One MDL, Johnson & Johnson talcum powder (MDL 2738), holds 69,376 of the 204,987 actions pending in federal MDLs, about one in three (33.8%), according to the JPML report dated November 2, 2026.
MDLs the JPML classifies as products liability make up 65 of 164 pending MDL dockets (39.6%) but hold 94.0% of all pending MDL actions (192,725), according to the JPML's November 2, 2026 reports by actions pending and by MDL type.
Source: JPML report, November 2, 2026 (PDF); JPML report by MDL type, November 2, 2026 (PDF)
These are counts of civil actions in federal MDLs, not counts of people. A pending count rises when actions are filed in or transferred to an MDL and falls when actions are dismissed, settled, remanded or otherwise closed. It does not measure injuries, the strength of any claim or how a case will turn out. Read the limits.
Largest 12-month increases in pending MDL actions

Monthly pending actions in the four fastest-growing large MDLs

| JPML report date | Depo-Provera (MDL 3140) | Bard implanted port catheter (MDL 3081) | Social media adolescent addiction (MDL 3047) | Uber passenger sexual assault (MDL 3084) |
|---|---|---|---|---|
| November 3, 2025 | 1,225 | 2,127 | 2,172 | 2,783 |
| December 2, 2025 | 1,470 | 2,463 | 2,191 | 2,949 |
| January 5, 2026 | 1,752 | 2,545 | 2,243 | 3,078 |
| February 2, 2026 | 2,098 | 2,674 | 2,325 | 3,188 |
| March 2, 2026 | 3,099 | 2,828 | 2,407 | 3,291 |
| April 1, 2026 | 3,490 | 3,044 | 2,465 | 3,391 |
| May 1, 2026 | 3,769 | 3,187 | 2,527 | 3,437 |
| June 1, 2026 | 5,508 | 3,376 | 2,664 | 3,571 |
| July 1, 2026 | 5,830 | 3,564 | 2,893 | 3,940 |
| August 3, 2026 | 6,294 | 3,734 | 3,137 | 4,397 |
| September 1, 2026 | 6,403 | 3,734 | 3,208 | 4,588 |
| October 1, 2026 | 6,412 | 4,140 | 3,824 | 4,916 |
| November 2, 2026 | 6,413 | 4,345 | 4,309 | 4,548 |
Every MDL with 1,000 or more pending actions
Ordered by pending actions in the November 2, 2026 report. Change compares the same MDL number in the November 3, 2025 report. The CSV has every MDL in either report.
| MDL | JPML title | Pending, Nov '25 | Pending, Nov '26 | Change | Change (%) |
|---|---|---|---|---|---|
| 2738 | IN RE: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation | 67,229 | 69,376 | +2,147 | +3% |
| 2846 | IN RE: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation | 23,932 | 23,299 | −633 | −3% |
| 2873 | IN RE: Aqueous Film-Forming Foams Products Liability Litigation | 15,249 | 15,270 | +21 | +0.1% |
| 3060 | IN RE: Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation | 10,723 | 12,743 | +2,020 | +19% |
| 2789 | IN RE: Proton-Pump Inhibitor Products Liability Litigation (No. II) | 11,331 | 11,404 | +73 | +0.6% |
| 2666 | IN RE: Bair Hugger Forced Air Warming Devices Products Liability Litigation | 8,757 | 8,414 | −343 | −4% |
| 3004 | IN RE: Paraquat Products Liability Litigation | 6,433 | 6,635 | +202 | +3% |
| 2570 | IN RE: Cook Medical, Inc., IVC Filters Marketing, Sales Practices and Products Liability Litigation | 6,969 | 6,467 | −502 | −7% |
| 3140 | IN RE: Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation | 1,225 | 6,413 | +5,188 | +424% |
| 3084 | IN RE: Uber Technologies, Inc., Passenger Sexual Assault Litigation | 2,783 | 4,548 | +1,765 | +63% |
| 3081 | IN RE: Bard Implanted Port Catheter Products Liability Litigation | 2,127 | 4,345 | +2,218 | +104% |
| 3047 | IN RE: Social Media Adolescent Addiction/Personal Injury Products Liability Litigation | 2,172 | 4,309 | +2,137 | +98% |
| 2974 | IN RE: Paragard IUD Products Liability Litigation | 3,658 | 4,104 | +446 | +12% |
| 3094 | IN RE: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability Litigation | 2,914 | 4,082 | +1,168 | +40% |
| 2804 | IN RE: National Prescription Opiate Litigation | 2,965 | 2,877 | −88 | −3% |
| 3029 | IN RE: Covidien Hernia Mesh Products Liability Litigation (No. II) | 2,201 | 2,486 | +285 | +13% |
| 3092 | IN RE: Suboxone (Buprenorphine/Naloxone) Film Products Liability Litigation | 1,871 | 2,016 | +145 | +8% |
| 3044 | IN RE: Exactech Polyethylene Orthopedic Products Liability Litigation | 1,838 | 1,838 | 0 | 0% |
| 2875 | IN RE: Valsartan, Losartan, and Irbesartan Products Liability Litigation | 1,368 | 1,422 | +54 | +4% |
| 2921 | IN RE: Allergan Biocell Textured Breast Implant Products Liability Litigation | 1,477 | 1,370 | −107 | −7% |
Largest declines
A falling count can follow dismissals, settlements, remands or other closings. It does not show that anyone was paid or that the litigation ended.
| MDL | JPML title | Pending, Nov '25 | Pending, Nov '26 | Change |
|---|---|---|---|---|
| 2741 | IN RE: Roundup Products Liability Litigation | 4,490 | 916 | −3,574 |
| 2740 | IN RE: Taxotere (Docetaxel) Products Liability Litigation | 2,988 | 6 | −2,982 |
| 2924 | IN RE: Zantac (Ranitidine) Products Liability Litigation | 1,812 | 806 | −1,006 |
| 2848 | IN RE: Zostavax (Zoster Vaccine Live) Products Liability Litigation | 826 | 0 | −826 |
| 2846 | IN RE: Davol, Inc./C.R. Bard, Inc., Polypropylene Hernia Mesh Products Liability Litigation | 23,932 | 23,299 | −633 |
Pending MDL actions by JPML docket type
Types are the JPML's own categories from its November 2, 2026 report by MDL type. Shares are of all 164 dockets and 204,987 pending actions in the report.
| JPML docket type | Dockets | Share of dockets | Pending actions | Share of pending actions |
|---|---|---|---|---|
| Products Liability | 65 | 39.6% | 192,725 | 94.0% |
| Miscellaneous | 15 | 9.1% | 8,588 | 4.2% |
| Antitrust | 38 | 23.2% | 1,215 | 0.6% |
| Data Breach and Consumer Privacy | 20 | 12.2% | 1,086 | 0.5% |
| Sales Practices | 9 | 5.5% | 642 | 0.3% |
| Common Disaster | 3 | 1.8% | 409 | 0.2% |
| Intellectual Property | 7 | 4.3% | 177 | 0.1% |
| Securities | 4 | 2.4% | 90 | <0.1% |
| Air Disaster | 2 | 1.2% | 49 | <0.1% |
| Employment Practices | 1 | 0.6% | 6 | <0.1% |
Methodology and limits
Sources. The JPML's monthly Pending MDL Dockets reports “by actions pending” for the 13 report dates from November 3, 2025, to November 2, 2026, and the same-date reports “by MDL type.” We downloaded every file from jpml.uscourts.gov on . The JPML's listing page links only the current month; earlier reports remain at the addresses listed below.
Extraction and checks. We converted each PDF to text and read every row's district, judge, MDL number, title, pending actions and total actions. For every report, the number of rows equals the report's docket total, the pending and total actions add up to the report's printed totals, and all eight size-range summaries recompute from the rows. Every MDL in each report also appears in that day's report by MDL type. The 5 months already published in our MDL Monitor (July 2026 to November 2026) parse to exactly the released rows.
Measures. Change is an MDL's pending actions in the November 2, 2026 report minus its pending actions in the November 3, 2025 report, for MDL numbers listed in both. Percentage change divides that difference by the earlier count; findings round it to the nearest whole percent and round shares to one decimal place. A “large” MDL has at least 1,000 pending actions in the latest report. MDLs that are new in the latest report have no 12-month change, and MDLs no longer listed count only toward the earlier report's totals. Short names such as “Depo-Provera” abbreviate the JPML titles, which the tables and CSVs give in full.
Limits. The JPML counts civil actions, not plaintiffs; one action can include more than one plaintiff. A pending count is net of new filings, transfers and closings, so it does not show how many actions were filed. The reports cover federal MDLs only; related cases in state courts are not counted. Report dates fall on the first business days of each month and are not evenly spaced. We do not compare total (historical) actions across the window: they jump when MDL 2885 first appears in the March 2, 2026 report with 391,222 historical actions.
Reproduce it. The scripts in scripts/data-studies/2026-11-mdl-trends/ of our site repository rebuild the data from the PDFs (checking each file's SHA-256), recompute every number on this page and render the charts. A test recomputes the headline findings from the archived reports.
These are the JPML's numbers and our arithmetic. They are not legal advice, estimates or predictions. People's Justice is a legal-information publisher and is not a law firm. See our publishing methodology and corrections process.
Source reports
- November 3, 2025: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 4c8c598b9758498aab4718d338e66d1500f67422a3cca15c76b4606a52c6319c
- December 2, 2025: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 02acf48f3753a5d17dc09e4ee84d0e460027389de4f653ecca013779e70164e3
- January 5, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 06530a1c2ebac91f0d6af33fe6725e8973427fa50e81c12904714b66ffe25dad
- February 2, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 f9835afbad7a23a9659b69dd62fbf5eed580adf11b2612dd2d1cef0c329fd922
- March 2, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 beecdb1fcbd37f00fb3bf694da03c8e4d4f464842e985188c016256451ee6de6
- April 1, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 68ffe884f3c48877155ab7287fdfb11b0021a08e2697e5d46508495624dbb070
- May 1, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 8d89078404ffcd3d0b40de93f8d646ee1d183db42d72cf421df3fad5fea42cae
- June 1, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 6bdcea2af28e199204452e6910b712c1947e3a3d14c711d14bab32c4c26564fb
- July 1, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 1aa2181acd5a6f3331031d53f796e05a3b6b3c07a24c873fc0b1afee0a2165b2
- August 3, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 1c5e7f62c95a583f853f088e5b5cbccb02fbcfd1c9b54e7a57db357cc0b60ba9
- September 1, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 1113fa70c31288dbf8f7d809d6c46a48367f517edf1f91d38dccc71d8fa6eaa0
- October 1, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 9e1e4117add7291dad785a154fc336cc724a8252224a2a41f215189faf6f762d
- November 2, 2026: by actions pending (PDF) · by MDL type (PDF)
Retrieved 2026-11-05 · SHA-256 2854e718c8e5305bf4dd2e0096a887d392d53c1eb3b2616c9c88df45079fc47e
Cite, embed or republish
You may republish these charts and data, free of charge, under Creative Commons Attribution 4.0. Credit the Judicial Panel on Multidistrict Litigation as the original source and People's Justice for the analysis, link to this page, and say if you changed anything. The license does not imply JPML endorsement. “Free” here describes the license; it is not an offer of legal services. More terms and logos are in our press and data kit.
Citation
People's Justice research team. "Which mass torts grew fastest? 12 months of federal MDL data." People's Justice, November 5, 2026. Data: Judicial Panel on Multidistrict Litigation, Pending MDL Dockets by Actions Pending, reports dated November 3, 2025, to November 2, 2026. https://peoplesjustice.info/data/mdl-growth-2026. Licensed CC BY 4.0.
Embed: largest 12-month increases in pending MDL actions
Paste this HTML into your page. The image is served from our site; you may also download it and host it yourself with the same credit.
<figure style="margin:0"><img src="https://peoplesjustice.info/data/mdl-growth-2026/charts/largest-increases.png" alt="Horizontal bar chart of the 8 largest increases in pending actions among federal MDLs between the JPML reports dated November 3, 2025, and November 2, 2026. Depo-Provera (MDL 3140): +5,188, from 1,225 to 6,413; Bard implanted port catheter (MDL 3081): +2,218, from 2,127 to 4,345; Johnson & Johnson talcum powder (MDL 2738): +2,147, from 67,229 to 69,376; Social media adolescent addiction (MDL 3047): +2,137, from 2,172 to 4,309; Hair relaxer (MDL 3060): +2,020, from 10,723 to 12,743; Uber passenger sexual assault (MDL 3084): +1,765, from 2,783 to 4,548; GLP-1 receptor agonist (MDL 3094): +1,168, from 2,914 to 4,082; Paragard IUD (MDL 2974): +446, from 3,658 to 4,104. Source: Judicial Panel on Multidistrict Litigation." width="1600" height="900" style="max-width:100%;height:auto"><figcaption style="font-size:12px">Chart: <a href="https://peoplesjustice.info/data/mdl-growth-2026" rel="nofollow">People's Justice</a>, CC BY 4.0. Data: Judicial Panel on Multidistrict Litigation.</figcaption></figure>
Embed: monthly pending actions in the four fastest-growing large MDLs
Paste this HTML into your page. The image is served from our site; you may also download it and host it yourself with the same credit.
<figure style="margin:0"><img src="https://peoplesjustice.info/data/mdl-growth-2026/charts/monthly-growth.png" alt="Four line charts on the same zero-based scale showing pending actions in each monthly JPML report from Nov '25 to Nov '26. Depo-Provera (MDL 3140): 1,225, 1,470, 1,752, 2,098, 3,099, 3,490, 3,769, 5,508, 5,830, 6,294, 6,403, 6,412, 6,413; Bard implanted port catheter (MDL 3081): 2,127, 2,463, 2,545, 2,674, 2,828, 3,044, 3,187, 3,376, 3,564, 3,734, 3,734, 4,140, 4,345; Social media adolescent addiction (MDL 3047): 2,172, 2,191, 2,243, 2,325, 2,407, 2,465, 2,527, 2,664, 2,893, 3,137, 3,208, 3,824, 4,309; Uber passenger sexual assault (MDL 3084): 2,783, 2,949, 3,078, 3,188, 3,291, 3,391, 3,437, 3,571, 3,940, 4,397, 4,588, 4,916, 4,548. Source: Judicial Panel on Multidistrict Litigation." width="1600" height="900" style="max-width:100%;height:auto"><figcaption style="font-size:12px">Chart: <a href="https://peoplesjustice.info/data/mdl-growth-2026" rel="nofollow">People's Justice</a>, CC BY 4.0. Data: Judicial Panel on Multidistrict Litigation.</figcaption></figure>
About this study
Analysis and charts by the People's Justice research team, from public JPML records only. No outside experts were interviewed and no figures were estimated. We connect people with law firms, who may pay us for those connections; read how People's Justice makes money. Journalists can find our other datasets, logos and contact route in the press and data kit.